Latest Breaking News On - Peter wrighton smith - Page 1 : comparemela.com

Pure Transplant Solutions and Oxford Immunotec to Support Commercialization of Novel B Cell Measurement Assay for Early Detection of Tissue Injury

Pure Transplant Solutions and Oxford Immunotec to Support Commercialization of Novel B Cell Measurement Assay for Early Detection of Tissue Injury
massachusettsnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from massachusettsnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesComunidad autonoma de catalunaOxford immunotecPeter wrighton smithBlake harlanOriol bestardEmergent technologies incKidney internationalPure proteinBellvitge biomedical research institutePure transplant solutionsDrug administrationPerkinelmer incResearch useUniversity of oklahomaNational news

Pure Transplant Solutions, LLC and Oxford Immunotec, Ltd Announce Exclusive Sublicense Agreement to Support Commercialization of Novel B Cell Measurement Assay for Early Detection of Tissue Injury and Prevention of Organ Rejection

AUSTIN, Texas and OXFORD, U.K., Dec. 7, 2021 (SEND2PRESS NEWSWIRE) Pure Transplant Solutions, LLC (PTS), a developer of novel HLA based transplant diagnostics, and Oxford Immunotec, Ltd. (OI), a global diagnostics company part of PerkinElmer Inc., today announce an exclusive sublicense agreement in which PTS will obtain exclusive commercial rights to issued patents protecting a novel assay originally developed by Dr. Oriol Bestard, M.D., Ph.D. - News from Pure Transplant Solutions LLC, issued by Send2Press Newswire

United statesComunidad autonoma de catalunaOxford immunotecPeter wrighton smithBlake harlanOriol bestardEmergent technologies incKidney internationalPure proteinBellvitge biomedical research institutePure transplant solutionsDrug administrationPerkinelmer incResearch useUniversity of oklahomaPanel of reactive antibody

Pure Transplant Solutions, LLC and Oxford Immunotec, Ltd Announce Exclusive Sublicense Agreement to Support Commercialization of Novel B Cell Measurement Assay for Early Detection of Tissue Injury and Prevention of Organ Rejection

Pure Transplant Solutions, LLC and Oxford Immunotec, Ltd Announce Exclusive Sublicense Agreement to Support Commercialization of Novel B Cell Measurement Assay for Early Detection of Tissue Injury and Prevention of Organ Rejection
californianewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from californianewswire.com Daily Mail and Mail on Sunday newspapers.

Pure Transplant Solutions, LLC and Oxford Immunotec, Ltd Announce Exclusive Sublicense Agreement to Support Commercialization of Novel B Cell Measurement Assay for Early Detection of Tissue Injury and Prevention of Organ Rejection

Pure Transplant Solutions, LLC and Oxford Immunotec, Ltd Announce Exclusive Sublicense Agreement to Support Commercialization of Novel B Cell Measurement Assay for Early Detection of Tissue Injury and Prevention of Organ Rejection
floridanewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from floridanewswire.com Daily Mail and Mail on Sunday newspapers.

Pure Transplant Solutions, LLC and Oxford Immunotec, Ltd Announce Exclusive Sublicense Agreement to Support Commercialization of Novel B Cell Measurement Assay

eNewsChannels NEWS: Pure Transplant Solutions, LLC (PTS), a developer of novel HLA based transplant diagnostics, and Oxford Immunotec, Ltd. (OI), a global diagnostics company part of PerkinElmer Inc., today announce an exclusive sublicense agreement in which PTS will obtain exclusive commercial rights to issued patents protecting a novel assay originally developed by Dr. Oriol Bestard, M.D., Ph.D. :: News from eNewsChannels

United statesComunidad autonoma de catalunaOxford immunotecPeter wrighton smithBlake harlanOriol bestardEmergent technologies incKidney internationalPure proteinBellvitge biomedical research institutePure transplant solutionsDrug administrationPerkinelmer incResearch useUniversity of oklahomaPanel of reactive antibodies